Evidence map›Paper›PMID 18572290›Full record

ReviewAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2008

Fatigue in patients receiving maintenance dialysis: a review of definitions, measures, and contributing factors.

Manisha Jhamb, Steven D Weisbord, Jennifer L Steel, Mark Unruh

Open access · greenAbstract readReview
In one paragraph

Review in American journal of kidney diseases : the official journal of the National Kidney Foundation, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 131 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
131citing papers in PubMed, 5 pooled it
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

131 citing papers in PubMed, 5 syntheses or guidelines pooled it, 349 citations in OpenAlex.

  1. Pooled it
  2. Interventions for fatigue in people with kidney failure requiring dialysis.The Cochrane database of systematic reviews · 2023
    Pooled it
  3. Exercise training for adults undergoing maintenance dialysis.The Cochrane database of systematic reviews · 2022
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Treating hypertension in hemodialysis improves symptoms seemingly unrelated to volume excess.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2016
    Trial
  12. Trial
  13. Trial
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

71 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Manisha JhambWestern Pennsylvania Medical Center, Pittsburgh, PA, USA.
Steven D Weisbord
Jennifer L Steel
Mark Unruh
University of Pittsburgh Medical Center · USUPMC Hillman Cancer Center · USVA Pittsburgh Healthcare System · USWestern Pennsylvania Hospital · US

Funding

Impact of Nocturnal Hemodialysis on Sleep Apnea, Sleep Quality & Daytime SymptomsR01DK077785 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI UNRUH, MARK LYNN · 2007 to 2011
$1.3M
Sleep and Daytime Functioning in Chronic Kidney DiseaseK23DK066006 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI UNRUH, MARK LYNN · 2004 to 2008
$710k
NIDDK NIH HHS DK66006NIDDK NIH HHS DK77785NIDDK NIH HHS K23 DK066006NIDDK NIH HHS R01 DK077785
6 · The paper itself

Abstract

Fatigue is a debilitating symptom or side effect experienced by many patients on long-term dialysis therapy. Fatigue has a considerable effect on patient health-related quality of life and is viewed as being more important than survival by some patients. Renal providers face many challenges when attempting to reduce fatigue in dialysis patients. The lack of a reliable, valid, and sensitive fatigue scale complicates the accurate identification of this symptom. Symptoms of daytime sleepiness and depression overlap with fatigue, making it difficult to target specific therapies. Moreover, many chronic health conditions common in the long-term dialysis population may lead to the development of fatigue and contribute to the day-to-day and diurnal variation in fatigue in patients. Key to improving the assessment and treatment of fatigue is improving our understanding of potential mediators, as well as potential therapies. Cytokines have emerged as an important mediator of fatigue and have been studied extensively in patients with cancer-related fatigue. In addition, although erythropoietin-stimulating agents have been shown to mitigate fatigue, the recent controversy regarding erythropoietin-stimulating agent dosing in patients with chronic kidney disease suggests that erythropoietin-stimulating agent therapy may not serve as the sole therapy to improve fatigue in this population. In conclusion, fatigue is an important and often underrecognized symptom in the dialysis population. Possible interventions for minimizing fatigue in patients on long-term dialysis therapy should aim at improving health care provider awareness, developing improved methods of measurement, understanding the pathogenesis better, and managing known contributing factors.

Indexed as

FatigueCytokinesFollow-Up StudiesHumansKidney Failure, ChronicOutcome Assessment, Health CarePsychometricsQuality of LifeRenal DialysisTime FactorsCytokines

Identifiers

PMID18572290
PMCPMC2582327
OpenAlexW2001620396

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.